Katy Beckermann, Medical Director of GU Clinical Research at Tennessee Oncology, shared a post on X:
“Great keynote by Carl June at AACR, highlighting the transformative success of CAR-T in hematologic malignancies and the exciting wave of innovation aiming to overcome barriers in solid tumors.
From armored CAR designs and checkpoint strategies to microenvironment targeting the momentum is real and inspiring for kidney cancer.”
Other articles featuring Katy Beckermann on OncoDaily.
